Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi Centre, Double Blind, Placebo-controlled Study to Evaluate the Non Steroidal Anti-inflamatory Drugs (NSAIDS) Sparing Effect of Etanercept in Adult Subjects With Axial Involvement of Spondyloarthritis

NCT01298531 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01298531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01298531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi Centre, Double Blind, Placebo-controlled Study to Evaluate the Non Steroidal Anti-inflamatory Drugs (NSAIDS) Sparing Effect of Etanercept in Adult Subjects With Axial Involvement of Spondyloarthritis
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2011
Completion date
April 30, 2013
Enrollment
90 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

axial spondyloarthritis